Opens in a new tab

FMT Testimonial (ASD 15) Optimal for the treatment of Autism Spectrum Disorder

Step I Step Nagoya Representative, Ms. Ikuko Kojima Ikuko Kojima founded iStep Nagoya, a community for parents raising children with disabilities, based on her own experiences of lack of understanding of disabilities, prejudice, and being passed around by the world. The community provides parents with a place to connect offline and online, and an environment…

Step I Step Nagoya Representative, Ms. Ikuko Kojima

Ikuko Kojima founded iStep Nagoya, a community for parents raising children with disabilities, based on her own experiences of lack of understanding of disabilities, prejudice, and being passed around by the world. The community provides parents with a place to connect offline and online, and an environment where they can build a future together. We spoke with Ms. Kojima, a community representative and parent of a transplant-challenged child, at an academic conference.

–I understand that your son is cooperating in clinical research.

Yes, I finished my transplant in July 2023 and am in communication with the doctor for the clinical study report in January 2024. my 10 year old son has autism spectrum disorder with severe intellectual disabilities. He has had severe constipation since he was a baby and has always had to use medication to pass stools. He has been throwing tantrums when he has stools in his stomach, which is partly due to his autism spectrum disorder. When I asked parents in the same situation, many of them were troubled by stools, so I thought in my layman’s way that there might be a relationship between autistic spectrum disorder and stools. That is why when I heard from my colleagues at i-step about the Intestinal Flora Transplant Clinical Study Group and that they were looking for people to cooperate in clinical research at the study group, I did not hesitate to apply.

–Please tell us about your son’s condition prior to receiving the transplant.

Other than constipation, he is a very picky eater. We would like to provide dietary therapy, but he will not put food in his mouth due to his “obsession” from his imaginary idiosyncrasies, such as “I can’t eat foods/cookings that I have never seen before. In this sense, I believe that intestinal flora transplantation, in which bacterial fluid is introduced through the hips, is the best treatment. As for language, he could imitate and parrot back, but interaction was difficult, and he could only produce a few words, such as “poop”.
Stools are finally pooped out with the help of medication. When I went into the clinical study, I had to stop the medication, so I was a little anxious about that.

–When did you learn about the intestinal flora transplant itself?

When my son was 2 or 3 years old, he had a particularly bad case of constipation that really bothered me. While searching the Internet for a solution, I found a stool transplant. In the days when the term “intestinal flora transplant” was still unheard of, the fecal transplant seemed to me to be a revolutionary method. My son is a picky eater, so it was difficult to get him to take his medicine by mouth. The method of inserting the drugs through the buttocks seemed truly revolutionary. At the time, however, I did not have the courage to travel all the way from Nagoya to Osaka, even to receive the transplant.
However, I had no hesitation in applying for this clinical research because I had such prior knowledge.

–Did you notice any changes in your son after the transplant?

First, there was a change in the stool. Not immediately after transplantation, but the colocolorized poop started to become moist stools. Although the stools are not stable, with some stools being columbites and others being banana-shaped, he now always has a bowel movement, even if it is a small one every day. When he has a bowel movement, he feels refreshed and is in a good mood.
There was also a change in his language. During the period he was undergoing transplantation, he took the Shinkansen bullet train between Nagoya and Shin-Osaka every week, and he seemed to enjoy the trip. She began to communicate what she wanted, such as packing her bags and uttering “Shinkansen” (bullet train). When she soiled her underwear, she once said “brown poo” and called my husband. Unfortunately, I was away for work, but until now, there have been no cases where he has said “poop” but with an adjective, including “brown”. With just one word, I know what my son is asking for. It speeds up the process of understanding him. The change in language has helped our family communicate much more smoothly.

–Expectations for the Intestinal Flora Transplant Clinical Study Group and your own future prospects.

I really appreciate the fact that the Intestinal Flora Transplant Clinical Study Group is focusing its research on autism spectrum disorder. There are many parents suffering from disabilities, not limited to autistic spectrum disorder. Until now, the general approach has been to correct the behavior of children with disabilities based on the belief that disabilities cannot be cured. We believe that the appearance of intestinal flora transplantation as a “treatment method” is a very big step forward in this situation. There must be a certain number of parents who would like to know more details about the experience. We would like to help such parents make a choice by sharing our son’s case.

The 7th Annual Conference [Report] is here.


Related Videos

Guest participation by Mr. Kojima [14th Roundtable Discussion with Loose Fungi].

Article Content

Related Articles

  • 城谷昌彦医師|IBS・潰瘍性大腸炎のQOLを変えるFMT治療の現在地

    日々の診療の中で、従来の標準治療だけでは十分に対応しきれない慢性的な消化器疾患。特に、潰瘍性大腸炎や過敏性腸症候群(IBS)を患う人々は、検査数値や画像所見だけでは見えにくい深い不安と、生活上の大きな制限を抱え続けている。 城谷バイオウェルネスクリニックの城谷昌彦医師が「腸内フローラ移植(FMT)」という新たな治療領域に関心を持った大きなきっかけ―――それは、他でもない先生自身が回腸嚢炎の治療法の一つとしてFMTを自ら受けた経験にあった。 自ら患者としてFMTを体験した医師は、臨床でNanoGAS®-FMT(水素ナノバブル水を用いた腸内フローラ移植)をどう活かし、患者の人生をどう変えているのか。そして、なぜ今、期待ばかりをあおることなく「慎重なエビデンスの検証」を訴え続けるのか。 「医療の成果は、単に症状や検査数値の改善だけではありません。患者さんが本来取り組みたかったことに再び向き合えるようになること、将来に前向きな気持ちを持てるようになることこそが、非常に大切な成果なのです。」 城谷医師の医療哲学と、2026年9月に開催される「第10回 一般財団法人腸内フローラ移植臨床 学術大会」に向けた見どころに迫る。 数値や画像には映らない「患者の不安」に向き合う 自らがFMTを受けた経験―――腸内細菌という「切り札」 「私自身、回腸嚢炎に対する治療法の一つであるFMTを大学の治験を通じて受けたことが、腸内フローラ移植に関心を持つ大きなきっかけでした」と、自らの患者体験と、消化器専門医としての深い葛藤を振り返る。 日々の診療において、従来の標準治療だけではどうしても対応しきれない患者の症状や経過に向き合うことは決して少なくない。中でも、潰瘍性大腸炎やIBS(過敏性腸症候群)の患者は、内視鏡検査や血液検査の数値だけでは測れない「いつお腹が痛くなるか分からない」「外出や外食が怖い」といった日常生活上の制限や精神的な不安を常時抱えている。 「腸内フローラを整えることは、単なる消化器症状の改善にとどまらず、患者さんのQOL(生活の質)を根本から向上させる可能性を秘めている」。自らの体験と臨床での実感から、腸内細菌へのアプローチを従来の治療を補完する「切り札」の一つとして見出すようになった。 NanoGAS®-FMTという新たな選択肢の可能性 大学の治験でFMTを受けたものの、大きな改善は見られなかったが、その可能性を感じることはできたという。数あるFMTの中でNanoGAS®-FMTを導入した理由は、「臨床現場での扱いやすさ」と「患者への負担軽減」にあったという。 従来の移植法と比較しても、患者への心身の負担に配慮しながら実施できる可能性を感じたことが大きな決定打となった。これまで既存の治療法を試しても十分な改善が得られなかった患者に対して、「腸内環境の再構築」という全く新しい選択肢を提示できるようになった意義は極めて大きい。 しかし、城谷医師は戒めを忘れない。 「一方で、FMTを『万能の治療法』のように扱うべきではないとも考えています。すべての患者さんに同じ結果が出るわけではありませんし、適応の見極め、既存治療との組み合わせ、そして治療前後の評価は極めて慎重に行う必要があります」 将来への不安を抱えた若い潰瘍性大腸炎患者の劇的な変化…

If you are concerned about your intestinal flora, start by consulting us.

Request FMT Treatment